Literature DB >> 8059602

Neuronal cytoskeletal abnormalities in human cerebral cortical dysplasia.

T Duong1, M J De Rosa, V Poukens, H V Vinters, R S Fisher.   

Abstract

The cytoskeletal abnormalities of cortical neurons in human cerebral cortical dysplasia were compared by immunohistochemical methods to the neurofibrillary tangles of Alzheimer's disease (AD). Surgical specimens from cortical resections performed for the treatment of intractable childhood seizures as well as autopsied samples from AD patients were analyzed with different antibodies directed against high- or medium-molecular mass neurofilament epitopes, phosphorylated or non-phosphorylated forms of neurofilaments, ubiquitin, the microtubule-associated protein tau, and paired helical filaments (PHF), a defining feature of AD tangles. A strong abnormal increase in immunoreactivity to the high and medium molecular mass neurofilament epitopes was seen in hypertrophic neurons of cortical dysplasia. These neurofilamentous accumulations of cortical dysplasia as well as AD tangles also displayed immunoreactivity with antibodies against phosphorylated and non-phosphorylated neuro-filament epitopes, tau and ubiquitin. Only the AD tangles, however, were immunoreactive to the antiserum to PHF. These results replicate and extend our previous findings that the neurofibrillary accumulations in cerebral cortical dysplasia share some common antigens with the neurofibrillary tangles of AD but do not demonstrate immunoreactivity to PHF antiserum. The results also suggest that the cytoskeletal abnormalities observed in neurons of cortical dysplasia may result in part from alterations in the level of expression, in phosphorylation state or in transport of cytoskeletal components.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8059602     DOI: 10.1007/bf00294176

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  24 in total

1.  Unilateral megalencephaly: hamartoma or neoplasm?

Authors:  J J Townsend; S L Nielsen; N Malamud
Journal:  Neurology       Date:  1975-05       Impact factor: 9.910

2.  Tau epitopes are incorporated into a range of lesions in Alzheimer's disease.

Authors:  C L Joachim; J H Morris; D J Selkoe; K S Kosik
Journal:  J Neuropathol Exp Neurol       Date:  1987-11       Impact factor: 3.685

Review 3.  New perspectives on Alzheimer's disease.

Authors:  D L Price
Journal:  Annu Rev Neurosci       Date:  1986       Impact factor: 12.449

4.  Reactivity of a panel of neurofilament antibodies on phosphorylated and dephosphorylated neurofilaments.

Authors:  G Shaw; M Osborn; K Weber
Journal:  Eur J Cell Biol       Date:  1986-10       Impact factor: 4.492

5.  Neuropathologic findings in cortical resections (including hemispherectomies) performed for the treatment of intractable childhood epilepsy.

Authors:  M A Farrell; M J DeRosa; J G Curran; D L Secor; M E Cornford; Y G Comair; W J Peacock; W D Shields; H V Vinters
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

6.  New aspects of the pathology of neurodegenerative disorders as revealed by ubiquitin antibodies.

Authors:  P N Leigh; A Probst; G E Dale; D P Power; J P Brion; A Dodson; B H Anderton
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

7.  Phosphorylation of tau by proline-directed protein kinase (p34cdc2/p58cyclin A) decreases tau-induced microtubule assembly and antibody SMI33 reactivity.

Authors:  C W Scott; P R Vulliet; C B Caputo
Journal:  Brain Res       Date:  1993-05-21       Impact factor: 3.252

8.  An assessment of the proliferative potential of 'balloon cells' in focal cortical resections performed for childhood epilepsy.

Authors:  M J De Rosa; M A Farrell; M M Burke; D L Secor; H V Vinters
Journal:  Neuropathol Appl Neurobiol       Date:  1992-12       Impact factor: 8.090

9.  Morphological substrates of infantile spasms: studies based on surgically resected cerebral tissue.

Authors:  H V Vinters; R S Fisher; M E Cornford; V Mah; D L Secor; M J De Rosa; Y G Comair; W J Peacock; W D Shields
Journal:  Childs Nerv Syst       Date:  1992-02       Impact factor: 1.475

10.  Hemimegalencephaly: a clinicopathological study of four cases.

Authors:  O Robain; C Floquet; N Heldt; F Rozenberg
Journal:  Neuropathol Appl Neurobiol       Date:  1988 Mar-Apr       Impact factor: 8.090

View more
  7 in total

Review 1.  Basic mechanisms of epileptogenesis in pediatric cortical dysplasia.

Authors:  Sara Abdijadid; Gary W Mathern; Michael S Levine; Carlos Cepeda
Journal:  CNS Neurosci Ther       Date:  2014-11-18       Impact factor: 5.243

2.  Cortical dysplasia localized by [11C]methionine positron emission tomography: case report.

Authors:  Padma Vasantha Madakasira; Robert Simkins; Tanjore Narayanan; Kelly Dunigan; Raymond J Poelstra; Joseph Mantil
Journal:  AJNR Am J Neuroradiol       Date:  2002-05       Impact factor: 3.825

Review 3.  Surgical pathology of epilepsy-associated non-neoplastic cerebral lesions: a brief introduction with special reference to hippocampal sclerosis and focal cortical dysplasia.

Authors:  Hajime Miyata; Tomokatsu Hori; Harry V Vinters
Journal:  Neuropathology       Date:  2013-03-27       Impact factor: 1.906

4.  Alzheimer's disease-type neurofibrillary degeneration in verrucose dysplasias of the cerebral cortex.

Authors:  M A Morán; A Probst; C Navarro; P Gómez-Ramos
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

Review 5.  A review of gene expression patterns in the malformed brain.

Authors:  Mercedes F Paredes; Scott C Baraban
Journal:  Mol Neurobiol       Date:  2002-08       Impact factor: 5.590

Review 6.  Cytoskeletal proteins in cortical development and disease: actin associated proteins in periventricular heterotopia.

Authors:  Gewei Lian; Volney L Sheen
Journal:  Front Cell Neurosci       Date:  2015-04-01       Impact factor: 5.505

7.  Chronic temporal lobe epilepsy is associated with enhanced Alzheimer-like neuropathology in 3×Tg-AD mice.

Authors:  Xiao-Xin Yan; Yan Cai; Jarod Shelton; Si-Hao Deng; Xue-Gang Luo; Salvatore Oddo; Frank M Laferla; Huaibin Cai; Gregory M Rose; Peter R Patrylo
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.